Evidence map›Paper›PMID 31024032›Full record

ArticleScientific reports2019

Chitosan-based hydrogel to support the paracrine activity of mesenchymal stem cells in spinal cord injury treatment.

M Boido, M Ghibaudi, P Gentile, E Favaro, R Fusaro, C Tonda-Turo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 143 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. 3D Culture of MSCs for Clinical Application.Bioengineering (Basel, Switzerland) · 2024
    Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

M BoidoNeuroscience Institute Cavalieri Ottolenghi, Department of Neuroscience, University of Torino, Orbassano, 10043, Italy.
M GhibaudiNeuroscience Institute Cavalieri Ottolenghi, Department of Neuroscience, University of Torino, Orbassano, 10043, Italy.
P GentileSchool of Engineering, Newcastle University, Newcastle Upon Tyne, NE1 7RU, United Kingdom.
E FavaroDepartment of Medical Science, University of Turin, Torino, 10126, Italy.
R FusaroDepartment of Mechanical and Aerospace Engineering - PolitoBIOMed Lab, Politecnico of Torino, Torino, 10129, Italy.
C Tonda-TuroDepartment of Mechanical and Aerospace Engineering - PolitoBIOMed Lab, Politecnico of Torino, Torino, 10129, Italy. chiara.tondaturo@polito.it.
Neuroscience Institute · ITPolytechnic University of Turin · ITNewcastle University · GBUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced therapies which combine cells with biomaterial-based carriers are recognized as an emerging and powerful method to treat challenging diseases, such as spinal cord injury (SCI). By enhancing transplanted cell survival and grafting, biomimetic hydrogels can be properly engineered to encapsulate cells and locate them at the injured site in a minimally invasive way. In this work, chitosan (CS) based hydrogels were developed to host mesenchymal stem cells (MSCs), since their paracrine action can therapeutically enhance the SC regeneration, limiting the formation of a glial scar and reducing cell death at the injured site. An injectable and highly permeable CS-based hydrogel was fabricated having a rapid gelation upon temperature increase from 0 to 37 °C. CS was selected as former material both for its high biocompatibility that guarantees the proper environment for MSCs survival and for its ability to provide anti-inflammatory and anti-oxidant cues. MSCs were mixed with the hydrogel solution prior to gelation. MSC viability was not affected by the CS hydrogel and encapsulated MSCs were able to release MSC-vesicles as well as to maintain their anti-oxidant features. Finally, preliminary in vivo tests on SCI mice revealed good handling of the CS solution loading MSCs during implantation and high encapsulated MSCs survival after 7 days.

Indexed as

Mesenchymal Stem Cell TransplantationParacrine CommunicationAnimalsCell DeathCell LineCell ProliferationCells, ImmobilizedCell SurvivalChitosanElastic ModulusGlycerophosphatesHumansHydrogelsHydrogen-Ion ConcentrationMaleMesenchymal Stem Cellsbeta-glycerophosphoric acidChitosanGlycerophosphatesHydrogelsWater

Identifiers

PMID31024032
PMCPMC6483991
OpenAlexW2942171115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.